Sarosy GA - Search Results

1

Phase I study of alpha 2-interferon plus doxorubicin in patients with solid tumors.

Sarosy GA, Brown TD, Von Hoff DD, Spiegel RJ, Golando JP, Beougher KL, Kuhn JG, Kisner DL. Sarosy GA, et al. Cancer Res. 1986 Oct;46(10):5368-71. Cancer Res. 1986. PMID: 3756887

2

Rationale for and conduct of a phase I clinical trial with interferon alfa-2b plus doxorubicin.

Von Hoff DD, Sarosy G, Brown TD, Kuhn JG, Kisner DL. Von Hoff DD, et al. Semin Oncol. 1986 Sep;13(3 Suppl 2):72-7. Semin Oncol. 1986. PMID: 3764442

3

A phase I clinical and pharmacological study of weekly intravenous infusions of piritrexim (BW301U).

Weiss GR, Sarosy GA, Shenkenberg TD, Williams T, Clendeninn NJ, Von Hoff DD, Woolley JL, Liao SH, Blum MR. Weiss GR, et al. Among authors: sarosy ga. Eur J Cancer Clin Oncol. 1989 Dec;25(12):1867-73. doi: 10.1016/0277-5379(89)90360-x. Eur J Cancer Clin Oncol. 1989. PMID: 2632268

4

Phase I trial and biochemical evaluation of tiazofurin administered on a weekly schedule.

Melink TJ, Sarosy G, Hanauske AR, Phillips JL, Bayne JH, Grever MR, Jayaram HN, Von Hoff DD. Melink TJ, et al. Sel Cancer Ther. 1990 Spring;6(1):51-61. doi: 10.1089/sct.1990.6.51. Sel Cancer Ther. 1990. PMID: 2343202

5

A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction.

Kohn EC, Reed E, Sarosy GA, Minasian L, Bauer KS, Bostick-Bruton F, Kulpa V, Fuse E, Tompkins A, Noone M, Goldspiel B, Pluda J, Figg WD, Liotta LA. Kohn EC, et al. Among authors: sarosy ga. Clin Cancer Res. 2001 Jun;7(6):1600-9. Clin Cancer Res. 2001. PMID: 11410496 Clinical Trial.

6

A phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumors.

Azad N, Perroy A, Gardner E, Imamura CK, Graves C, Sarosy GA, Minasian L, Kotz H, Raggio M, Figg WD, Kohn EC. Azad N, et al. Among authors: sarosy ga. Cancer Biol Ther. 2009 Oct;8(19):1800-5. doi: 10.4161/cbt.8.19.9593. Cancer Biol Ther. 2009. PMID: 19738417 Free PMC article. Clinical Trial.

7

Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers.

Kohn EC, Reed E, Sarosy G, Christian M, Link CJ, Cole K, Figg WD, Davis PA, Jacob J, Goldspiel B, Liotta LA. Kohn EC, et al. Cancer Res. 1996 Feb 1;56(3):569-73. Cancer Res. 1996. PMID: 8564973 Clinical Trial.

8

Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancer.

Sarosy GA, Hussain MM, Seiden MV, Fuller AF, Nikrui N, Goodman A, Minasian L, Reed E, Steinberg SM, Kohn EC. Sarosy GA, et al. Cancer. 2010 Mar 15;116(6):1476-84. doi: 10.1002/cncr.24861. Cancer. 2010. PMID: 20091841 Free PMC article. Clinical Trial.

9

Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer.

Shapiro JD, Rothenberg ML, Sarosy GA, Steinberg SM, Adamo DO, Reed E, Ozols RF, Kohn EC. Shapiro JD, et al. Among authors: sarosy ga. Cancer. 1998 Nov 1;83(9):1980-8. Cancer. 1998. PMID: 9806657 Clinical Trial.

10

The absence of cumulative bone marrow toxicity in patients with recurrent adenocarcinoma of the ovary receiving dose-intense taxol and granulocyte colony stimulating factor.

Bicher A, Kohn E, Sarosy G, Davis P, Adamo DO, Jacob J, Christian M, Reed E. Bicher A, et al. Anticancer Drugs. 1993 Apr;4(2):141-8. doi: 10.1097/00001813-199304000-00003. Anticancer Drugs. 1993. PMID: 7683933

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters